(RTTNews) - Boehringer Ingelheim and Eli Lilly and Co.'s (LLY) Jardiance or empagliflozin was associated with a reduction in risk of hospitalization for heart failure compared with two other classes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results